Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Landscape of Circrnas in Gliomas Temozolomide Resistance: Insights Into Molecular Pathways Publisher



Mafi A1, 2 ; Hedayati N3 ; Kahkesh S4 ; Khoshayand S5 ; Alimohammadi M6 ; Farahani N7 ; Hushmandi K8
Authors
Show Affiliations
Authors Affiliations
  1. 1. Nutrition and Food Security Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Department of Clinical Biochemistry, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. School of Medicine, Iran University of Medical Science, Tehran, Iran
  4. 4. Faculty of Science, Shahid Chamran University of Ahvaz, Ahvaz, Iran
  5. 5. School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran
  6. 6. Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  7. 7. Department of Genetics and Molecular Biology, Isfahan University of Medical Sciences, Isfahan, Iran
  8. 8. Department of Food Hygiene and Quality Control, Division of Epidemiology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran

Source: Non-coding RNA Research Published:2024


Abstract

As the deadliest type of primary brain tumor, gliomas represent a significant worldwide health concern. Circular RNA (circRNA), a unique non-coding RNA molecule, seems to be one of the most alluring target molecules involved in the pathophysiology of many kinds of cancers. CircRNAs have been identified as prospective targets and biomarkers for the diagnosis and treatment of numerous disorders, particularly malignancies. Recent research has established a clinical link between temozolomide (TMZ) resistance and certain circRNA dysregulations in glioma tumors. CircRNAs may play a therapeutic role in controlling or overcoming TMZ resistance in gliomas and may provide guidance for a novel kind of individualized glioma therapy. To address the biological characteristics of circRNAs and their potential to induce resistance to TMZ, this review has highlighted and summarized the possible roles that circRNAs may play in molecular pathways of drug resistance, including the Ras/Raf/ERK PI3K/Akt signaling pathway and metabolic processes in gliomas. © 2024 The Authors
Other Related Docs
11. Exosomal Noncoding Rnas: Key Players in Glioblastoma Drug Resistance, Molecular and Cellular Biochemistry (2021)
12. Non-Coding Rnas and Brain Tumors: Insights Into Their Roles in Apoptosis, Frontiers in Cell and Developmental Biology (2022)
15. Circular Rnas: New Players in Thyroid Cancer, Pathology Research and Practice (2020)
24. Circular Rnas: New Genetic Tools in Melanoma, Biomarkers in Medicine (2020)
25. The Regulatory Role of Circular Rnas As Mirna Sponges in Cervical Cancer, Current Signal Transduction Therapy (2023)
26. Circular Rnas: A Small Piece in the Heart Failure Puzzle, Functional and Integrative Genomics (2024)
30. Circular Rnas-Mediated Angiogenesis in Human Cancers, Clinical and Translational Oncology (2023)
39. Microrna: A Novel Target of Curcumin in Cancer Therapy, Journal of Cellular Physiology (2018)
42. A Review on Expression and Regulatory Mechanisms of Mir-337-3P in Cancer, Journal of Biomolecular Structure and Dynamics (2024)